Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
Clinical trial NCT05347979 · COMPLETED
Trial details
- NCT number
- NCT05347979
- Sponsor
- Corcept Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-25
- Primary completion
- 2022-07-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.